
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
COVID-19-associated hepatic injury differential diagnosis
Introduction

Overview
Overview
COVID-19-associated hepatic Injury must be differentiated from other conditions that cause elevation of liver enzymes.
Differential Diagnosis
Differential Diagnosis
COVID-19-associated hepatic Injury must be differentiated from other conditions that cause elevation of liver enzymes.
| Disease | Clinical manifestations | Laboratory findings | Additional findings | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Signs | Transaminitis (elevated AST and ALT) | Viral markers | Autoimmune markers | ||||||
| Nausea & vomiting | Abdominal pain | Arthralgia | Jaundice | Hepatomegaly | ||||||
| Acute viral hepatitis | Hepatitis A[1][2] | +++ | ++ | + | +++ | + | +++ | HAV Ab | — |
|
| Hepatitis B[3] | +++ | ++ | ++ | +++ | + | +++ | HBs Ag, HBc Ab, HBe Ag | — |
| |
| Hepatitis C[4] | +++ | ++ | ++ | +++ | + | +++ | HCV Ab | — |
| |
| Hepatitis E[5] | ++ | ++ | +/- | ++ | + | +++ | HEV Ab | — |
| |
| CMV hepatitis[6] | +/- | ++ | – | + | + | ++ | CMV-specific immunoglobulin (Ig)M antibody | — |
| |
| EBV hepatitis[7] | +/- | ++ | – | +/- | + | ++ | Heterophile antibody test, monospot test | — |
| |
| Autoimmune hepatitis[8] | – | + | +/- | ++ | + | +++ | — | ANA, ASMA, anti SLA/LP, ANCA, ALKM-1 antibodies |
| |
| Alcoholic hepatitis[9] | +/- | + | – | + | – | AST>ALT | — | — |
| |
| Drug induced hepatitis[10] | +/- | + | – | + | + | ++ | — | — |
| |
| COVID-19-associated hepatic Injury | +[11] | +[12] | +[13] | – | +[13] | ++[14] | IgG/IgM Antibodies[15] | — |
| |
References
References
- ↑ Jeong SH, Lee HS (2010). “Hepatitis A: clinical manifestations and management”. Intervirology. 53 (1): 15–9. doi:10.1159/000252779. PMID 20068336.
- ↑ Nainan OV, Xia G, Vaughan G, Margolis HS (2006). “Diagnosis of hepatitis a virus infection: a molecular approach”. Clin Microbiol Rev. 19 (1): 63–79. doi:10.1128/CMR.19.1.63-79.2006. PMC 1360271. PMID 16418523.
- ↑ Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA; et al. (2018). “Hepatitis B virus infection”. Nat Rev Dis Primers. 4: 18035. doi:10.1038/nrdp.2018.35. PMID 29877316.
- ↑ Mukherjee R, Burns A, Rodden D, Chang F, Chaum M, Garcia N; et al. (2015). “Diagnosis and Management of Hepatitis C Virus Infection”. J Lab Autom. 20 (5): 519–38. doi:10.1177/2211068214563794. PMID 25609256.
- ↑ Kamar N, Dalton HR, Abravanel F, Izopet J (2014). “Hepatitis E virus infection”. Clin Microbiol Rev. 27 (1): 116–38. doi:10.1128/CMR.00057-13. PMC 3910910. PMID 24396139.
- ↑ Gupta P, Suryadevara M, Das A (2014). “Cytomegalovirus-induced hepatitis in an immunocompetent patient”. Am J Case Rep. 15: 447–9. doi:10.12659/AJCR.890945. PMC 4206484. PMID 25325934.
- ↑ Karadeniz A, Yesilbag Z, Kaya FÖ, Akgün FS (2018). “Acute hepatitis due to Epstein-Barr virus with cross-reacting antibodies to cytomegalovirus”. Indian J Med Microbiol. 36 (1): 143–144. doi:10.4103/ijmm.IJMM_17_378. PMID 29735847.
- ↑ Manns MP, Lohse AW, Vergani D (2015). “Autoimmune hepatitis–Update 2015”. J Hepatol. 62 (1 Suppl): S100–11. doi:10.1016/j.jhep.2015.03.005. PMID 25920079.
- ↑ Hosseini N, Shor J, Szabo G (2019). “Alcoholic Hepatitis: A Review”. Alcohol Alcohol. 54 (4): 408–416. doi:10.1093/alcalc/agz036. PMC 6671387 Check
|pmc=value (help). PMID 31219169. - ↑ Katarey D, Verma S (2016). “Drug-induced liver injury”. Clin Med (Lond). 16 (Suppl 6): s104–s109. doi:10.7861/clinmedicine.16-6-s104. PMC 6329561. PMID 27956449.
- ↑ Luo S, Zhang X, Xu H (2020). “Don’t Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19)”. Clin Gastroenterol Hepatol. 18 (7): 1636–1637. doi:10.1016/j.cgh.2020.03.043. PMC 7154217 Check
|pmc=value (help). PMID 32205220 Check|pmid=value (help). - ↑ “Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5”. Lancet Infect Dis. 20 (7): e148. 2020. doi:10.1016/S1473-3099(20)30370-4. PMID 32595044 Check
|pmid=value (help). External link in|title=(help) - ↑ 13.0 13.1 Li J, Fan JG (2020). “Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease”. J Clin Transl Hepatol. 8 (1): 13–17. doi:10.14218/JCTH.2020.00019. PMC 7132021 Check
|pmc=value (help). PMID 32274341 Check|pmid=value (help). - ↑ Bangash MN, Patel J, Parekh D (2020). “COVID-19 and the liver: little cause for concern”. Lancet Gastroenterol Hepatol. 5 (6): 529–530. doi:10.1016/S2468-1253(20)30084-4. PMC 7270582 Check
|pmc=value (help). PMID 32203680 Check|pmid=value (help). - ↑ Lippi G, Simundic AM, Plebani M (2020). “Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)”. Clin Chem Lab Med. 58 (7): 1070–1076. doi:10.1515/cclm-2020-0285. PMID 32172228 Check
|pmid=value (help). - ↑ Wang W, Xu Y, Gao R, Lu R, Han K, Wu G; et al. (2020). “Detection of SARS-CoV-2 in Different Types of Clinical Specimens”. JAMA. doi:10.1001/jama.2020.3786. PMC 7066521 Check
|pmc=value (help). PMID 32159775 Check|pmid=value (help). - ↑ “Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 – Volume 26, Number 8—August 2020 – Emerging Infectious Diseases journal – CDC”.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
